Endometriosis is a common health condition in women where the endometrial tissue, which is found in the lining of the uterus, appears and grows outside the uterine cavity. The endometrial tissue is shed from the body during menstruation. The tissue growing outside the uterine cavity is called endometrial implants. Endometriosis can also occur in the fallopian tubes, ovaries, pelvic cavity, vagina, cervix, and bladder. In rare cases, it has been reported in other parts of the body such as the lungs, brain, and skin. These implants are usually benign in nature. Women of reproductive age are often affected by this condition.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

Endometriosis: An overview

PART 05: Pipeline analysis

Pipeline molecules based on their mechanism

PART 06: Key buying criteria for endometriosis drugs

PART 07: Market landscape

Market overview

Five forces analysis

PART 08: Market segmentation by type of therapy

Hormone therapy

Market size and forecast

Pain medications

Market size and forecast

PART 09: Market segmentation by ROA

Oral

Parenteral

Intrauterine systems

Nasal spray

PART 10: Geographical segmentation

Global endometriosis drugs market by geography 2015-

2020

Endometriosis drugs market in Americas

Endometriosis drugs market in EMEA

Endometriosis drugs market in APAC

PART 11: Market drivers

Recurrence of endometriosis

Increased adoption on OCPs

Ineffective existing therapies leading to high unmet

need

PART 12: Impact of drivers

PART 13: Market challenges

Poor compliance rates leading to high dropouts

Surgeries as primary treatment option

Unavailability of proper diagnostic tools

PART 14: Impact of drivers and challenges

PART 15: Market trends

Replacement of GnRH agonists by GnRH antagonists

Increased focus on IUDs

Development of novel targets for treatment

PART 16: Vendor landscape

Competitive scenario

Key news

Major upcoming vendors

PART 17: Key vendor analysis

AbbVie

AstraZeneca

Bayer HealthCare

Pfizer

Other prominent vendors

PART 18: Appendix

List of abbreviations

PART 19: Explore Technavio